期刊文献+

非小细胞肺癌与慢性阻塞性肺病患者血清C反应蛋白水平的变化 被引量:1

Changes of C-reactive protein in patients with non-small-cell lung carcinoma and chronic obstructive pulmonary disease
原文传递
导出
摘要 目的探讨非小细胞肺癌(NSCLC)与慢性阻塞性肺病(COPD)患者的血清C反应蛋白(CRP)水平变化。方法采用速率散射法检测NSCLC组(46例)、NSCLC合并COPD组(30例)、COPD组(60例)和健康体检者对照组(38例)血清CRP水平。结果 NSCLC组和NSCLC合并COPD组血清CRP水平明显高于COPD和对照组[(19.32±2.15)mg/L和(23.09±1.98)mg/Lvs.(8.67±1.31)mg/L和(2.79±0.77)mg/L](P<0.01)。早期NSCLC患者血清CRP水平明显低于晚期患者[(14.52±2.34)mg/L vs.(23.29±1.81)mg/L](P<0.01),但明显高于COPD组及对照组(P<0.01)。血清CRP水平与肺癌病理分型及吸烟无相关性。结论慢性炎症在NSCLC及COPD中扮演重要的角色,在NSCLC中尤为明显。 Objective To investigate the changes of C-reactive protein(CRP) in patients with non-small cell lung carcinoma(NSCLC) and chronic obstructive pulmonary disease(COPD). MethodsSerum levels of CRP were detected by velocity and scattering method in 46 patients with NSCLC (group N),30 NSCLC patients with COPD(group NC), 60 patients with COPD)PD(group C) and 38healthy subjects(group D as the controls). Results Serum levels of CRP were significantly higher in groups of N and NC than those in groups of C and D[(19.32±2.15)mg/L and (23.09±1.98)mg/Lvs.(8.67±1.31) mg/L and (2.79±0.77)mg/L](P〈0.01). The patients with NSCLC in early stage had lower serum CRP than those with advanced NSCLC[(14.52±2.34)mg/L vs.(23.29±1.81)mg/L](P〈0.01),which was still higher than that in groups of C and D(P〈0.01). No association was found between serum CRP and histology and smoking status in the patients withNSCLC. Conclusion Chronic inflammation plays an important role in NSCLC and COPD,especially in the former.
出处 《江苏医药》 CAS 北大核心 2013年第6期690-692,共3页 Jiangsu Medical Journal
关键词 非小细胞肺癌 慢性阻塞性肺病 C反应蛋白 Non-small cell lung carcinoma Chronic obstructive pulmonary disease C-reactive protein
  • 相关文献

参考文献10

  • 1Coussens LM,Werb Z. Inflammation and cancer[J]. Nature, 2002,420(6917) : 860-867.
  • 2Pepys MB, Hirsehfield GM. C-reactive protein: a critical update[J]. J Clin Invest,2003,111(12) : 1805-1812.
  • 3Pinto-Plata V,Mullerova H,Toso JF,et al. C-reactive protein in patients with COPD, control smokers and non-smokers[J]. Thorax, 2006,61 (1) : 23-28.
  • 4Bolayirli M,Turna H,Orhanoglu T,et al. C-reactive protein as an acute phase protein in cancer patients[J]. Med Oncol, 2007,24(3):338-344.
  • 5Heikkila K, Ebrahim S, Lawlor DA. A systemic review of the association between circulating eoncentrations of C reactive protein and cancer[J]. J Epidemiol Community Health, 2007, 61(9) :824-833.
  • 6Koshiol J, Rotunno M, Consonni D, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study[J]. PLoS One, 2009,4 (10) :e7380.
  • 7Jones JM, McGonigle NC, McAnespie M, et al. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer[J]. Lung Cancer, 2006,53 (1) : 97- 101.
  • 8Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history[J]. Eur Respir J,2009,34(2) : 380-386.
  • 9Sin DD, Man SF, McWilliams A, et al. Progression of airways dysplasia and C-reactive protein in smokers at high risk of lung cancer[J]. Am J Respir Crit Care Med, 2006,173 (5) : 535-539.
  • 10Hara M, Yonei A, Ayabe T, et al. Postoperative serum C-reactive protein levels in non-small cell lung cancer patients [J]. Ann Thorac Cardiovasc Surg, 2010,16(2).. 85-90.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部